Skip to main content
Clinical Trials/NCT01220921
NCT01220921
Completed
Phase 3

Neurosurgery Patient Outcomes in Treating Spinal Disorders

Greenwich Hospital13 sites in 2 countries198 target enrollmentSeptember 2010

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Symptomatic Lumbar Disc Herniation
Sponsor
Greenwich Hospital
Enrollment
198
Locations
13
Primary Endpoint
Site and Physician Compliance
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The creation of a multi-center cooperative research group encompassing academic and community-based spinal practices . . .

Registry
clinicaltrials.gov
Start Date
September 2010
End Date
September 2012
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Grade I degenerative or isthmic spondylolisthesis recalcitrant to non-invasive therapies for at least 3 months or Lumbar degenerative disc herniation with radiculopathy refractory to non-invasive therapies for at least 6 weeks

Exclusion Criteria

  • History of previous lumbar spine surgery
  • Significant motor weakness (3/5) (i.e. foot drop)
  • Cancer, infection, or fracture
  • Pregnancy

Outcomes

Primary Outcomes

Site and Physician Compliance

Time Frame: 1 Year

Goal = 80% compliance in enrolling 20 patients over 1 year with completed outcomes instruments

SF-36 version 1

Time Frame: 1-Year

Health-realted quality of life outcome measure

Secondary Outcomes

  • Oswestry Disability Index (ODI)(1 Year)
  • Visual Analog Pain Score(1 Year)
  • Return to Work(1 Year)
  • 30 day complications(30 days)
  • Delayed Surgical Complications(1 year)

Study Sites (13)

Loading locations...

Similar Trials